Histocompatibility antigens DR and DQ in chronic obstructive pulmonary disease

B. Nunez, J. Sauleda, J. R. González, J. Milà, C. Crespí, J. Pons, J. García, J. M. Antó, A. Noguera, M. Orozco, E. Monsó, F. Gómez, A. Agustí, PAC-COPD Group (Palma de Mallorca, Barcelona, Badalona, Spain)

Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Session: COPD: exacerbation and clinical problems
Session type: Thematic Poster Session
Number: 3478
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Nunez, J. Sauleda, J. R. González, J. Milà, C. Crespí, J. Pons, J. García, J. M. Antó, A. Noguera, M. Orozco, E. Monsó, F. Gómez, A. Agustí, PAC-COPD Group (Palma de Mallorca, Barcelona, Badalona, Spain). Histocompatibility antigens DR and DQ in chronic obstructive pulmonary disease. Eur Respir J 2009; 34: Suppl. 53, 3478

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Antielastin antibodies in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012


Diabetes and chronic obstructive pulmonary disease
Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes
Year: 2019


Chronic obstructive pulmonary disease
Source: Eur Respir Mon; 2009: 45: 25–31
Year: 2009

Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2015; 70: 80-98
Year: 2015


Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2014; 65: 1-17
Year: 2014


Chronic obstructive pulmonary disease
Source: Eur Respir Monogr 2013; 62: 1-18
Year: 2013


Genetic risks in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 454s
Year: 2003

Therapeutic responses in asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD
Year: 2008


Rhinovirus-infection in chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 591s
Year: 2002

PG1 Asthma and chronic obstructive pulmonary disease
Source: Paris 2018 - Educational material
Year: 2018

Association of clinical features with HLA in chronic pulmonary thromboembolism
Source: Eur Respir J 2005; 25: 131-138
Year: 2005



Anemia in chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012

Chronic obstructive pulmonary disease: phenotyping and differential diagnosis
Source: International Congress 2018 – Imaging Grand Round
Year: 2018


Telemedicine in chronic obstructive pulmonary disease
Source: Breathe 2016; 12: 350-356
Year: 2016



Association of clinical characteristics with HLA in chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003

Immune checkpoints in chronic obstructive pulmonary disease
Source: Eur Respir Rev, 26 (144) 170045; 10.1183/16000617.0045-2017
Year: 2017



Autoimmunity, T-cells and STAT-4 in the pathogenesis of chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 3-5
Year: 2004


Periodontitis and chronic obstructive pulmonary disease
Source: Annual Congress 2006 - COPD and inflammation
Year: 2006


Immunological profiling of chronic obstructive airways disease and idiopathic pulmonary fibrosis
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020


PG9 Chronic obstructive pulmonary disease exacerbations
Source: Paris 2018 - Educational material
Year: 2018